![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Hubei Yitai Pharmaceutical Co., Ltd. Tianmen City Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Aciclovir, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2019-238 - Rev 01
This Chemical Type CEP, issued on May 31, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 968 associated with this CEP further emphasizes